| Insider · 34 positions | Net Shares per Quarter (+ Bought / − Sold) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Role | Shares Held ↑ | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Paul Bolno | — | 33K | — | +33K | — | — | +100K | — | — | — | — | — | — | — | — | — | — | — |
| Rene Russo | — | 36K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Sara Cotter | — | 41K | — | — | — | — | — | — | — | — | — | +41K | — | — | +100K | — | — | — |
| Redonda Miller | — | 44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tamsin Berry | — | 50K | — | +50K | — | — | — | +50K | — | — | — | +50K | — | — | — | +50K | — | — |
| Kevin F Mclaughlin | — | 50K | — | +50K | — | +50K | — | +50K | — | — | — | +100K | — | — | — | — | — | — |
| MCGUIRE TERRANCE | — | 50K | — | +50K | — | — | — | +50K | — | -1.6M | — | -62K | — | — | — | +50K | — | — |
| Marc Elia | — | 50K | — | +50K | — | — | — | +50K | — | — | — | +50K | — | — | — | +50K | — | — |
| Christine Lindenboom | — | 50K | — | — | — | — | — | +50K | — | — | — | +50K | — | — | — | +30K | — | +150K |
| Ajay Royan | — | 50K | — | +50K | — | — | — | +8K | +100K | — | — | — | — | — | — | — | — | — |
| Tomas J. Heyman | — | 50K | — | — | — | — | — | — | — | — | — | — | — | — | — | +50K | — | — |
| Michael S Wyzga | — | 50K | — | — | — | — | — | — | — | — | — | — | — | — | — | +50K | — | — |
| Clive Meanwell | — | 50K | — | — | — | — | — | — | — | — | — | — | — | — | — | +50K | — | — |
| Ellen R Marram | — | 63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Howard Mayer | — | 75K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Srishti Gupta | — | 100K | — | — | — | — | — | — | — | — | — | +100K | — | — | — | — | — | — |
| Rebecca Dabora | Chief Tech and Manuf Officer | 100K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +100K |
| Julie Green | Chief Human Resources Officer | 108K | — | — | +634K | — | -50K | — | +1.3M | — | — | — | +240K | — | — | — | — | — |
| William E. Duke | Chief Financial Officer | 108K | — | — | +584K | — | -50K | — | +1.3M | — | — | — | — | +200K | +750K | — | — | — |
| Robert D. Allen III | Chief Scientific Officer | 114K | — | — | +587K | — | -46K | — | +1.3M | — | — | — | — | +400K | — | +600K | — | — |
| Timothy Edward Lee | Chief Commercial Officer | 118K | — | — | +634K | — | -50K | — | +1.3M | — | — | +600K | — | — | — | — | — | — |
| Elham Hershberger | Chief Development Officer | 175K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jane Henderson | Chief Financial Officer | 175K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tillman U. Gerngross | Chief Executive Officer | 175K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Lynn Connolly | Chief Medical Officer | 175K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jill Andersen | Chief Legal Officer, Secretary | 182K | — | — | +752K | — | -83K | — | +1.4M | — | — | — | — | +725K | — | — | — | +475K |
| Jeremy Gowler | COO & CCO | 400K | — | — | — | — | — | — | — | — | — | — | — | +400K | — | — | — | +625K |
| Peter Schmidt | Chief Medical Officer | 400K | — | — | — | — | — | — | — | — | — | — | — | +400K | — | — | — | +500K |
| Stacy Price | Chief Tech. and Manuf. Officer | 400K | — | — | — | — | — | — | — | — | — | — | — | +400K | — | — | +475K | — |
| David Hering | Chief Executive Officer | 950K | — | — | — | — | — | — | — | — | — | — | — | +950K | — | — | — | +1.6M |
| Michael Mina | CMO and Chief Epidemiologist | 1.1M | +1.1M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Redmile Group, LLC | 3.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| MITHRIL II LP | — | 11.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Adimab, LLC | — | 21.7M | — | — | — | — | — | — | — | — | — | — | -5.0M | — | — | — | — | — |